Development of mouse hybridomas for production of monoclonal antibodies specific to Burkholderia mallei and Burkholderia pseudomallei

Hybridoma

Volumn 25, Issue 4, 2006, Pages 193-201

  Feng, Shaw Huey ^a   Tsai, Shien ^a   Rodriguez, Jose ^a   Newsome, Tamara ^a   Emanuel, Peter ^b   Lo, Shyh Ching ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b Chemical Biological Engineering Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; PROTEINASE K;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; HYBRIDOMA; IMMUNIZATION; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPLEEN CELL;

BURKHOLDERIA; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; PSEUDOMONAS;

EID: 33750979839     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2006.25.193     Document Type: Article

References (21)

1. Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, Davis TM, Looareesuwan S, and Pitakwatchara N: Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989;159:890-899.
2. Howe C, Sampath A, and Spotnitz M: The pseudomallei group: a review. J Infect Dis 1971;11:413-425.
3. Leelarasamee A and Bovornkitti S: Melioidosis: review and update. Rev Infect Dis 1989;11:413-425.
4. Howe C: Glanders. In: The Oxford Medicine. Christian HA (Ed.). Oxford University Press, New York, 1950, pp. 185-202.
5. Howe C and Miller WR: Human glanders: report of six cases. Ann Intern Med 1947;26:93-115.
6. Centers for Disease Control and Prevention: Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep 2000;49:1-14.
7. Rosebury T and Kabat EA: Bacterial warfare. A critical analysis of the available agents, their possible military applications, and the means for protection against them. J Immunol 1947;56:7-96.
8. Redfearn, MS, Palleroni NJ, and Stanier RY: A comparative study of Pseudomonas pseudomallei and Bacillus mallei. J Gen Microbiol 1966;43:293-313.
9. Rogul M, Brendle JJ, Haapala DK, and Alexander AD: Nucleic acid similarities among Pseudomonas pseudomallei, Pseudomonas multivorans and Actinobacillus mallei. J Bacteriol 1970;101:827-835.
10. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, and Lipman DJ. Gapped BLAST and PLI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-3402.
11. Cravitz L and Miller WR: Immunologic studies with malleomyces mallei and Malleomyces pseudomallei. Serological relationships between M. mallei and M. pseudomallei. J Infect Dis 1950;86: 46-51.
12. Brett P, Deshazer D, and Woods D: Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int J Syst Bacteriol 1998;48:317-320.
13. Anuntagool N and Sirisinha S: Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei. Microbiol Immunol 2002;46:143-150.
14. Feng SH and Lo SC: Induced mouse spleen B-cell proliferation and secretion of immunoglobulin by lipid-associated membrane proteins of Mycoplasma fermentans Incognitus and Mycoplasma penetrans. Infect Immun 1994;62:3916.
15. Yokoyama WM: Antibody detection and preparation. In: Current Protocols in Immunology. Coligan JE, Kurisbeek AM, Margulies DH, Shevach EM, and Strober W (Eds.). John Wiley & Sons, New York, 1991, Chapter 2.5.
16. Burtnick M, Brett P, and Woods D: Molecular and physical characterization of Burkholderia mallei O antigen. J Bacteriol 2002;184:849-852.
17. Sirisinha S, Anuntagool N, Intachote P, Wuthiekanun V, Putucheary SD, Vadivelu J, and White NJ: Antigenic differences between clinical and environmental isolates of Burkholderia pseudomallei. Microbiol Immunol 1998;42:731-737.
18. Steinmetz I, Rohde M, and Brenneke B: Purification and characterization of an exopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. Infect Immun 1995;63:3959-3965.
19. Perry M, MacLean L, Schollaardt T, Bryan L, and Ho M: Structural characterization of lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect. Immun 1995;63:3348-3352.
20. Recjseudker S, DeShazer D, Sokol P, and Woods D: Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun 2001; 69:34-44.
21. Anuntagool N, Aramsri P, Panichakul T, Wuthiekanun V, Kinoshita R, White N, and Sirisinha S: Antigenic heterogeneity of lipopolysaccharide among Burkholderia pseudomallei clinical isolates. Southeast Asian J Trop Med Public Health 2003;31S:146-152.